Demant Sells Oticon Medical to Impilo in Strategic Divestment

"Demant, a leading hearing healthcare group from Denmark, has agreed to sell Oticon Medical to the Nordic investment company Impilo. Oticon Medical specializes in bone anchored hearing solutions. As part of the deal, Demant will provide transitional support to help Impilo establish Oticon Medical as an independent business, including joint product development. The transaction is pending regulatory approvals. Plesner law firm advised Demant on the sale."

In the recent transaction involving the divestment of Oticon Medical, the law firm Plesner advised Demant A/S. Demant, a leading hearing healthcare group based in Denmark and listed on Nasdaq Copenhagen, has signed an agreement to sell Oticon Medical to Impilo, a Nordic investment company focused on healthcare investments. As part of the agreement, Demant will provide transitional support to Impilo as they work to develop Oticon Medical into a stand-alone business, which will include collaborative efforts in product development and the supply of sound processors. The core M&A team from Plesner that participated in this transaction included Thomas Holst Laursen, Simon Västernäs, Louise Lund, Kirstine Juel Månsson, and Kasper Nørgaard Carlsen. The press release does not specify their seniority or practice areas.

Demant Sells Oticon Medical to Impilo in Strategic Divestment

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads